Who
Eugene Bauer
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, Evommune; Director, Kadmon Holdings.
In numbers
- Trades disclosed
- 22
- Buys
- 1
- Sells
- 0
- Bought
- $12K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 15 Dec 2016
- Last trade
- 16 Apr 2026
- Last filed
- 17 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Apr 2026filed 17 Apr 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,117 at $0.00 | filing |
| 16 Apr 2026filed 17 Apr 2026 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,117 at $0.00 | filing |
| 9 Dec 2025filed 11 Dec 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code F | $26K1,478 at $17.84 | filing |
| 8 Dec 2025filed 19 Dec 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —206,355 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN Evommuneoption or derivative · Biotechnology | SEC FORM 4 Code C | —12,500 | filing |
| 7 Nov 2025filed 12 Nov 2025 | EVMN EvommuneBiotechnology | SEC FORM 4 Code C | —25,812 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code D | $15K3,077 at $4.84 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code D | $135K25,000 at $5.38 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code D | $154K25,000 at $6.15 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code D | $721K100,000 at $7.21 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code D | $430K85,034 at $5.06 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code D | $574K96,975 at $5.92 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdings | SEC FORM 4 Code D | $16K1,716 at $9.50 | filing |
| 9 Nov 2021filed 9 Nov 2021 | Kadmon Holdings | SEC FORM 4 Code D | $48K5,000 at $9.50 | filing |
| 12 May 2021filed 13 May 2021 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code A | —96,975 at $0.00 | filing |
| 13 May 2020filed 14 May 2020 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code A | —85,034 at $0.00 | filing |
| 15 May 2019filed 16 May 2019 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code A | $229K100,000 at $2.29 | filing |
| 27 Jul 2018filed 30 Jul 2018 | Kadmon Holdingsoption or derivative | SEC FORM 4 Code A | $84K25,000 at $3.35 | filing |
| 8 Aug 2017filed 8 Aug 2017 | Kadmon Holdings | SEC FORM 4 Bought | $12K5,000 at $2.36 | filing |
News
No headline names them, or the companies they trade most, lately.